Nov 09, 2022
185:131
For every 131 shares held, investors received 185. The price per share adjusted from $18.50 to $13.10.
The split itself did not change the total investment value.
Boule Diagnostics AB (STO:BOUL) operates in the Medical specialties industry.
Boule Diagnostics AB company overviewBoule Diagnostics AB's most recent stock split was on November 9, 2022. It was a 185-for-131 forward split, so shareholders received 185 shares for every 131 they held.
Boule Diagnostics AB (STO:BOUL) has split its stock 2 times: a 4-for-1 split on June 1, 2018 and a 185-for-131 split on November 9, 2022.
Boule Diagnostics AB has split its stock 2 times. This history records 2 forward splits between June 1, 2018 and November 9, 2022.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Boule Diagnostics AB's 185-for-131 split on November 9, 2022, every 131 shares became 185 shares.
Boule Diagnostics AB has not announced a new split in our records. Its most recent split was on November 9, 2022, 3 years ago. Companies announce splits in advance, and any new STO:BOUL split will appear on this page.
Already premium?